{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:45:12Z","timestamp":1790628312619,"version":"4.1.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Glycogen storage disease subtypes I and III (GSD I and GSD III) are monogenic inherited disorders of metabolism that disrupt glycogen metabolism. Unavailability of glucose in GSD I and induction of gluconeogenesis in GSD III modify energy sources and possibly, mitochondrial function. Abnormal mitochondrial structure and function were described in mice with GSD Ia, yet significantly less research is available in human cells and ketotic forms of the disease. We hypothesized that impaired glycogen storage results in distinct metabolic phenotypes in the extra- and intracellular compartments that may contribute to pathogenesis. Herein, we examined mitochondrial organization in live cells by spinning-disk confocal microscopy and profiled extra- and intracellular metabolites by targeted LC-MS\/MS in cultured fibroblasts from healthy controls and from patients with GSD Ia, GSD Ib, and GSD III. Results from live imaging revealed that mitochondrial content and network morphology of GSD cells are comparable to that of healthy controls. Likewise, healthy controls and GSD cells exhibited comparable basal oxygen consumption rates. Targeted metabolomics followed by principal component analysis (PCA) and hierarchical clustering (HC) uncovered metabolically distinct poises of healthy controls and GSD subtypes. Assessment of individual metabolites recapitulated dysfunctional energy production (glycolysis, Krebs cycle, succinate), reduced creatinine export in GSD Ia and GSD III, and reduced antioxidant defense of the cysteine and glutathione systems. Our study serves as proof-of-concept that extra- and intracellular metabolite profiles distinguish glycogen storage disease subtypes from healthy controls. We posit that metabolite profiles provide hints to disease mechanisms as well as to nutritional and pharmacological elements that may optimize current treatment strategies.<\/jats:p>","DOI":"10.3389\/fendo.2020.579981","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T07:52:35Z","timestamp":1606117955000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Metabolic Profiling in Human Fibroblasts Enables Subtype Clustering in Glycogen Storage Disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Luciana","family":"Hannibal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jule","family":"Theimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Wingert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Klotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Bierschenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Nitschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Spiekerkoetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Gr\u00fcnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0000000000000181","article-title":"Hepatic glycogen storage disorders: what have we learned in recent years","volume":"18","author":"Burda","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-18-0120","article-title":"Biochemical and clinical aspects of glycogen storage diseases","volume":"238","author":"Ellingwood","year":"2018","journal-title":"J Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/TRD-160006","article-title":"Glycogen storage diseases: Diagnosis, treatment and outcome","volume":"1","author":"Chen","year":"2016","journal-title":"Trans Sci Rare Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"44408","DOI":"10.1038\/srep44408","article-title":"Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa)","volume":"7","author":"Farah","year":"2017","journal-title":"Sci Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.15690\/vramn.v69i7-8.1112","article-title":"Mitochondrial dysfunction in children with hepatic forms of glycogen storage disease","volume":"69","author":"Kurbatova","year":"2014","journal-title":"Vestnik Rossiiskoi akademii meditsinskikh nauk"},{"key":"B6","first-page":"497","article-title":"Hepato-nephromegalia glykogenica (Glykogenspeichernkrankheit der Leber und Nieren)","volume":"82","author":"von Gierke","year":"1929","journal-title":"Beitr Path Anat"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1126\/science.8211187","article-title":"Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a","volume":"262","author":"Lei","year":"1993","journal-title":"Science"},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(18)38504-1","article-title":"Glucose-6-phosphatase of the liver in glycogen storage disease","volume":"199","author":"Cori","year":"1952","journal-title":"J Biol Chem"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196810312791803","article-title":"Functional differentiation of glycogenoses of the liver with respect to the use of glycerol","volume":"279","author":"Senior","year":"1968","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(18)43502-8","article-title":"Type Ib glycogen storage disease is caused by a defect in the glucose-6-phosphate translocase of the microsomal glucose-6-phosphatase system","volume":"255","author":"Lange","year":"1980","journal-title":"J Biol Chem"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(80)80418-5","article-title":"Neutropenia and impaired neutrophil migration in type IB glycogen storage disease","volume":"97","author":"Beaudet","year":"1980","journal-title":"J Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13023-020-01503-8","article-title":"Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib","volume":"15","author":"Grunert","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s10038-006-0045-x","article-title":"Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey","volume":"51","author":"Endo","year":"2006","journal-title":"J Hum Genet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118799","article-title":"Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle","volume":"98","author":"Shen","year":"1996","journal-title":"J Clin Invest"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1967.tb00134.x","article-title":"The subgroups of type 3 glycogenosis","volume":"2","author":"Van Hoof","year":"1967","journal-title":"Eur J Biochem"},{"key":"B16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0022-3476(05)81652-X","article-title":"Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III","volume":"116","author":"Ding","year":"1990","journal-title":"J Pediatr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/(SICI)1098-1004(1997)9:1<37::AID-HUMU6>3.0.CO;2-M","article-title":"A nonsense mutation due to a single base insertion in the 3\u2019-coding region of glycogen debranching enzyme gene associated with a severe phenotype in a patient with glycogen storage disease type IIIa","volume":"9","author":"Shen","year":"1997","journal-title":"Hum Mutat"},{"key":"B18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bone.2016.02.012","article-title":"Reduced bone mineral density in glycogen storage disease type III: evidence for a possible connection between metabolic imbalance and bone homeostasis","volume":"86","author":"Melis","year":"2016","journal-title":"Bone"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-018-0192-1","article-title":"Sirtuin signaling controls mitochondrial function in glycogen storage disease type Ia","volume":"41","author":"Cho","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.07.017","article-title":"Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia","volume":"69","author":"Gjorgjieva","year":"2018","journal-title":"J Hepatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-018-0149-4","article-title":"Insulin-resistance in glycogen storage disease type Ia: linking carbohydrates and mitochondria","volume":"41","author":"Rossi","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/metabo9100235","article-title":"Targeted Metabolic Profiling of Methionine Cycle Metabolites and Redox Thiol Pools in Mammalian Plasma, Cells and Urine","volume":"9","author":"Behringer","year":"2019","journal-title":"Metabolites"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2011.03.008","article-title":"The MMACHC proteome: hallmarks of functional cobalamin deficiency in humans","volume":"103","author":"Hannibal","year":"2011","journal-title":"Mol Genet Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117645","article-title":"Mutations in the glucose-6-phosphatase gene are associated with glycogen storage disease types 1a and 1aSP but not 1b and 1c","volume":"95","author":"Lei","year":"1995","journal-title":"J Clin Invest"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e1000514","DOI":"10.1371\/journal.pbio.1000514","article-title":"Quiescent fibroblasts exhibit high metabolic activity","volume":"8","author":"Lemons","year":"2010","journal-title":"PLoS Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15292","article-title":"Fibroblast-specific genome-scale modelling predicts an imbalance in amino acid metabolism in Refsum disease","author":"Wegrzyn","year":"2020","journal-title":"FASEB J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e201301009","DOI":"10.5936\/csbj.201301009","article-title":"Statistical methods for the analysis of high-throughput metabolomics data","volume":"4","author":"Bartel","year":"2013","journal-title":"Comput Struct Biotechnol J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2174\/2213235X11301010092","article-title":"Multivariate Analysis in Metabolomics","volume":"1","author":"Worley","year":"2013","journal-title":"Curr Metabolomics"},{"key":"B29","article-title":"Fibroblast culture in the diagnosis of genetic metabolic diseases: comparative histochemical, ultrastructural, and biochemical studies","volume":"5","author":"Landing","year":"1979","journal-title":"Perspect Pediatr Pathol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.7888\/juoeh.12.411","article-title":"Some properties of fibroblasts from a patient with debrancher deficiency","volume":"12","author":"Furutani","year":"1990","journal-title":"J UOEH"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-018-0207-y","article-title":"Polycystic kidney features of the renal pathology in glycogen storage disease type I: possible evolution to renal neoplasia","volume":"41","author":"Gjorgjieva","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddw224","article-title":"Progressive development of renal cysts in glycogen storage disease type I","volume":"25","author":"Gjorgjieva","year":"2016","journal-title":"Hum Mol Genet"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1304-0","article-title":"Rapid \u2018glycaemic swings\u2019 induce nitrosative stress, activate poly(ADP-ribose) polymerase and impair endothelial function in a rat model of diabetes mellitus","volume":"52","author":"Horvath","year":"2009","journal-title":"Diabetologia"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s00125-009-1387-7","article-title":"A rat model of glycaemic variability","volume":"52","author":"Zaccardi","year":"2009","journal-title":"Diabetologia"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3181e655b6","article-title":"Glycogen storage disease type III diagnosis and management guidelines","volume":"12","author":"Kishnani","year":"2010","journal-title":"Genet Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1089","article-title":"HMDB 4.0: the human metabolome database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.579981\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T01:24:26Z","timestamp":1618449866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.579981\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":36,"alternative-id":["10.3389\/fendo.2020.579981"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.579981","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,23]]},"article-number":"579981"}}